News

Highly pathogenic avian influenza reached Antarctica’s mainland in early 2024, leaving Australia, New Zealand and Pacific ...
Despite progress since COVID-19, the U.S. remains vulnerable to pandemics like H5N1, and withdrawing from the WHO would ...
Abingdon Health announced a strategic partnership with Okos Diagnostics on Monday to co-develop, manufacture and ...
Outbreaks of bird flu in mammals more than doubled across the world last year, raising the risk that the virus could ...
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...
The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...
The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...
Ostriches on a British Columbia farm have died of the avian flu. Canada ordered hundreds of others to be culled. But two top ...
The Company had previously expected to advance the program to late-stage development with the U.S. Department of Health and Human Services (HHS); however, today Moderna received notice that HHS will ...
Researchers identified a novel genotype (D1.1) of highly pathogenic avian influenza H5N1 spreading among wild birds, poultry, ...
The U.S. withdrew from treaty negotiations on President Trump's first day in office.
Brazil identified fresh bird flu cases in wild animals, which it said should not have any commercial impact, and is ...